DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment

Amyloid. 2021 Jun;28(2):134-135. doi: 10.1080/13506129.2020.1830272. Epub 2020 Oct 12.

Authors

Ana Roteta Unceta Barrenechea^{1

2}, Carmen Lahuerta Pueyo^{3

2}, Jorge Melero Polo^{4

2}, Sebastián Menao Guillén^{3

2}, Alejandro Andrés Gracia^{1

2}, Pablo Revilla Marti^{4

2}, Miguel Ángel Aibar Arregui^{5

2}

Affiliations

¹ Department of Nuclear Medicine (UCMHMNA), Hospital Clínico Universitario de Zaragoza (HCUZ), Aragón, Spain.
² IIS-Aragón, Zaragoza, Spain.
³ Department of Clinical Biochemistry, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.
⁴ Department of Cardiology, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.
⁵ Department of Internal Medicine, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.

PMID: 33043707
DOI: 10.1080/13506129.2020.1830272

No abstract available

Publication types

Letter
Comment

MeSH terms

Amyloid Neuropathies, Familial* / genetics
Humans
Mutation
Prealbumin* / genetics
Prevalence

Substances

Prealbumin